Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-arm, Multi-stage (MAMS), Pragmatic, Blinded (Patient and Outcome Assessor), Multicentre, Randomised Controlled Trial (RCT) With an Internal Pilot, to Evaluate the Use of Several In-theatre Interventions, Used Alone or in Combination, to Reduce SSI Rates in Patients Undergoing Abdominal Surgery.

NCT03838575 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT03838575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03838575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-arm, Multi-stage (MAMS), Pragmatic, Blinded (Patient and Outcome Assessor), Multicentre, Randomised Controlled Trial (RCT) With an Internal Pilot, to Evaluate the Use of Several In-theatre Interventions, Used Alone or in Combination, to Reduce SSI Rates in Patients Undergoing Abdominal Surgery.
Lead sponsor
University of Birmingham
Phase
Phase 3
Overall status
Unknown status
Start date
March 1, 2019
Completion date
August 31, 2023
Enrollment
6,610 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

surgery, surgery--complications, surgical site infection, surgical wound infection